About this trial
Background:
Substance use disorders (SUD) can be considered disorders in the way people process incentives, learn, and make decisions. To understand why some people develop SUD, researchers need to develop reliable tests that show how people think and learn. This natural history study seeks to develop a set of tasks that could then be used to test how people learn and make decisions.
Objective:
To develop and validate behavioral tasks that could be used in future studies.
Eligibility:
Healthy people aged 18-45 years from the Baltimore area. They must also be enrolled in the NIDA screening protocol.
Design:
Participants will perform different tasks. Most tasks require 1-4 study visits; some may require up to 12. Visits are 1-14 days apart. All visits will last about 1-7 hours.
Participants will perform tasks on a computer. As they work they may be given different stimuli:
Smells. Participants will sniff odors through a plastic tube or mask on their nose.
Flavors. Participants will wear a mouthpiece and small amounts of different flavored liquids will be placed in their mouth.
Pictures. Participants will look at different images.
Sounds. Participants will wear headphones and various sounds will be played for them.
Food. Participants may be asked to eat a meal before, during, or after a task. The researchers will provide the meal.
During each task, participants will wear sensors to monitor their heart rate, blood pressure, breathing, and other physical changes in their bodies.
Some participants will have a functional magnetic resonance imaging (fMRI) scan. They will lie on a table that slides into a cylinder. They will perform tasks on a computer screen during the fMRI.
Eligibility criteria
Qualifiers
None
Disqualifiers
Male or female, aged 18-45 years old. Justification: Many neural processes change with age, and these changes could introduce unwanted variability in both behavioral and MRI signals.
In good general health.
Right-handed.
History of neurological illnesses or neurosurgery including but not limited to cerebrovascular accident, Parkinson disease, Alzheimer disease, Huntington disease, CNS tumor, significant head trauma with sequelae, multiple sclerosis or other demyelinating diseases, epilepsy, movement disorders. The MAI will also retain discretion to exclude based on a history of a neurological illness or trauma that may compromise data integrity.
Trial design
Treatments tested in this trial
- MRI
Treatment groups
Locations
1Sponsors and collaborators
National Institute on Drug Abuse (NIDA)
Lead sponsor